Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-01-08

FDA Approved: BILTRICIDE — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for Biltricide (praziquantel) from Bayer HealthCare Pharmaceuticals Inc. This approval results in an updated labeling to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BILTRICIDE (praziquantel)

Snippet

SUPPL AP for BILTRICIDE (PRAZIQUANTEL)